Bicara Therapeutics Inc. ... (BCAX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
12.90
0.06 (0.51%)
At close: Jan 15, 2025, 1:24 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 |
Net Income | -51.98M | -37.84M |
Depreciation & Amortization | 19.00K | 10.00K |
Stock-Based Compensation | 1.90M | 810.00K |
Other Working Capital | -9.62M | 4.95M |
Other Non-Cash Items | 14.06M | n/a |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | -9.62M | 4.95M |
Operating Cash Flow | -45.63M | -32.08M |
Capital Expenditures | -586.00K | -192.00K |
Acquisitions | n/a | n/a |
Purchase of Investments | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | -586.00K | -192.00K |
Debt Repayment | n/a | n/a |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | 272.35M | 31.54M |
Financial Cash Flow | 272.50M | 31.70M |
Net Cash Flow | 226.28M | -573.00K |
Free Cash Flow | -46.21M | -32.27M |